Differentiating and Treating Conjunctivitis versus Scleritis
Conjunctivitis is typically a self-limiting condition with minimal complications, while scleritis is a severe ocular inflammation requiring aggressive systemic treatment to prevent vision loss. 1, 2
Clinical Differentiation
Conjunctivitis
- Presentation: Redness, discharge, and mild discomfort
- Pain level: Mild to moderate discomfort
- Discharge:
- Viral: Watery discharge
- Bacterial: Mucopurulent discharge
- Allergic: Watery discharge with itching
- Lymph nodes: Preauricular lymphadenopathy common in viral conjunctivitis 3, 4
- Visual acuity: Usually preserved
- Examination findings:
- Diffuse conjunctival injection
- Follicular or papillary reaction
- Membranes/pseudomembranes in severe cases
- Cornea typically clear
Scleritis
- Presentation: Severe, deep ocular pain (often radiating to temple/jaw)
- Pain level: Moderate to severe, often waking patient from sleep
- Discharge: Minimal to none
- Visual changes: May have decreased visual acuity (15.9% of cases) 1
- Examination findings:
- Deep, violaceous injection that doesn't blanch with phenylephrine
- Scleral edema and thickening
- Nodules in nodular scleritis
- Scleral thinning in necrotizing forms
- May have associated anterior uveitis
- Ocular complications in 58.8% of cases 1
Diagnostic Approach
Key Diagnostic Features
- Pain intensity: Mild in conjunctivitis, severe in scleritis
- Redness pattern:
- Conjunctivitis: Diffuse, bright red, blanches with phenylephrine
- Scleritis: Deep, violaceous, doesn't blanch with phenylephrine
- Slit lamp examination:
- Conjunctivitis: Surface involvement only
- Scleritis: Deep scleral involvement, may see nodules or thinning
- Associated findings:
- Conjunctivitis: Discharge, follicles/papillae
- Scleritis: Scleral edema, anterior uveitis
Diagnostic Tests
For conjunctivitis:
For scleritis:
Treatment Approaches
Conjunctivitis Treatment
Viral conjunctivitis:
Bacterial conjunctivitis:
Allergic conjunctivitis:
Special cases:
Scleritis Treatment
Non-necrotizing scleritis (diffuse or nodular):
- Oral NSAIDs as first-line therapy
- Oral corticosteroids if NSAIDs insufficient
- 56.4% of diffuse and 21.4% of nodular cases require systemic corticosteroids or immunosuppressants 1
Necrotizing scleritis:
Posterior scleritis:
- Systemic immunosuppression (100% require systemic treatment)
- High risk of complications (85.7%) 1
Infectious scleritis:
- Targeted antimicrobial therapy (systemic and topical)
- Avoid corticosteroids until infection controlled 6
Complications and Referral
Conjunctivitis Complications
- Generally minimal (13.5% in episcleritis) 1
- Usually no decrease in visual acuity
- Refer to ophthalmologist if:
Scleritis Complications
- Much more common (58.8% of cases) 1
- Visual acuity decrease in 15.9% 1
- Scleral thinning, perforation, uveitis
- Associated with systemic disease in approximately 30% of cases 2, 5
- All cases require ophthalmology referral
Key Takeaways
- Pain severity is a critical differentiator - mild in conjunctivitis, severe in scleritis
- Conjunctivitis typically resolves without sequelae, while scleritis can threaten vision
- Most conjunctivitis cases can be managed with topical therapy, while scleritis often requires systemic treatment
- Scleritis has a strong association with systemic autoimmune diseases and requires interdisciplinary management between ophthalmologists and rheumatologists/internists 2, 5